Gerzina Christopher, Potter Eric, Haleem Amgad M, Dabash Sherif
Department of Orthopaedic Surgery and Rehabilitation, Texas Tech Health Sciences Center, 3601 4th St, 4th floor, Lubbock, Texas, 79430, USA.
Department of Medical Education, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso. Medical Education Building, 2200 5001 El Paso Drive, El Paso, Texas, 79905, USA.
J Clin Orthop Trauma. 2020 Feb;11(Suppl 1):S142-S148. doi: 10.1016/j.jcot.2019.05.025. Epub 2019 May 31.
Socket prosthesis attachment is the current gold standard for limb amputees. Osseointegrated implantation is a novel technique that has many proposed advantages over the current gold standard. Clear advantages for its use over socket prosthetic attachment has been well established in literature. It decreases socket problems as pinching, pressure points, chronic skin problems and frequent socket change due to atrophy of muscles.
We reviewed primary research articles documenting complication rates and outcome measures in patients with osseointegrated prosthesis implantation after limb amputation.
Nine studies were identified with a total of 211-242 patients. Clinical, radiographic, and functional outcomes, as well as complications were considered. The mean duration of follow-up was greater than 12 months in all studies.
Osseointegration is an effective alternative to socket prosthesis in transfemoral amputees. Transtibial and upper extremity implants are underreported in the literature and clear indication for their effectiveness over socket prosthesis does not exist. Minor complications are most common, such as soft tissue infections, and may be mitigated in the future by improvements in surgical technique and implant design.The level of evidence is 3.
接受腔假体连接是目前肢体截肢者的金标准。骨整合植入是一种新技术,与当前的金标准相比有许多潜在优势。文献中已充分证实其相对于接受腔假体连接的明显优势。它减少了诸如挤压、压痛点、慢性皮肤问题以及因肌肉萎缩导致的频繁更换接受腔等接受腔相关问题。
我们回顾了记录肢体截肢后接受骨整合假体植入患者并发症发生率和结局指标的原始研究文章。
共确定了9项研究,涉及211 - 242名患者。考虑了临床、影像学和功能结局以及并发症。所有研究的平均随访时间均超过12个月。
对于大腿截肢者,骨整合是接受腔假体的一种有效替代方案。文献中关于胫骨截肢和上肢植入的报道较少,且不存在其相对于接受腔假体有效性的确切证据。轻微并发症最为常见,如软组织感染,未来可能通过手术技术和植入物设计的改进得到缓解。证据级别为3级。